Cargando…

WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil

 : Evidence-informed decision-making (EIDM) requires the balancing of numerous and often conflicting factors. During the SARS-CoV-2 pandemic, sound and fair EIDM procedures were challenged by time constraints and limited evidence. Beneficial effects had to be weight against public health impacts bey...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, L, Bimczok, S, Lehner, J, Stratil, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593559/
http://dx.doi.org/10.1093/eurpub/ckac129.543
_version_ 1784815190424944640
author Arnold, L
Bimczok, S
Lehner, J
Stratil, J
author_facet Arnold, L
Bimczok, S
Lehner, J
Stratil, J
author_sort Arnold, L
collection PubMed
description  : Evidence-informed decision-making (EIDM) requires the balancing of numerous and often conflicting factors. During the SARS-CoV-2 pandemic, sound and fair EIDM procedures were challenged by time constraints and limited evidence. Beneficial effects had to be weight against public health impacts beyond COVID-19, broad societal consequences, or individual liberties. Evidence-to-decision (EtD) frameworks are neither able nor intended to replace stakeholder participation, but can serve as a tool to ensure the relevance and completeness of criteria to be considered for EIDM in public health and guideline development. Employing ‘best-fit’ framework synthesis, we used the WHO-INTEGRATE framework as a starting point to develop the WHO-INTEGRATE COVID-19 framework version 1.0. WICID 1.0 is based on a content analysis of comprehensive strategy documents to guide policy makers in implementing new or decrease existing measures to protect against COVID-19 in Germany. WICID 1.0 was validated by coding the framework against an updated set of the key strategy documents, and key strategy documents addressing non-pharmacological measures in long-term care facilities. In total, 12 key strategy documents were analysed to develop WICID 1.0, and 18 + 23 documents were analyzed for its refinement towards WICID 2.0. The revised framework consists of 11 + 1 criteria and includes implications for the health of individuals and populations due to and beyond COVID-19, infringement on liberties and fundamental human rights, acceptability and equity considerations, societal, environmental and economic implications, as well as implementation, resource and feasibility considerations. Validation found high consistency with minor revisions between WICID 1.0 and 2.0. WICID can be a tool to support researchers, practitioners, and policy makers to systematically integrate evidence and ethics and to balance of health, societal and other considerations when reflecting on PH interventions targeting COVID-19. KEY MESSAGES: • Due to the rapidly developing pandemic, decision-making process often did not include the views of all affected stakeholders and did not adequately include all criteria and considerations of relevance. • The WICID Framework can serve as a tool to support decision-makers in accounting for relevant considerations and criteria, even when not all stakeholders could be included.
format Online
Article
Text
id pubmed-9593559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95935592022-11-04 WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil Arnold, L Bimczok, S Lehner, J Stratil, J Eur J Public Health Parallel Programme  : Evidence-informed decision-making (EIDM) requires the balancing of numerous and often conflicting factors. During the SARS-CoV-2 pandemic, sound and fair EIDM procedures were challenged by time constraints and limited evidence. Beneficial effects had to be weight against public health impacts beyond COVID-19, broad societal consequences, or individual liberties. Evidence-to-decision (EtD) frameworks are neither able nor intended to replace stakeholder participation, but can serve as a tool to ensure the relevance and completeness of criteria to be considered for EIDM in public health and guideline development. Employing ‘best-fit’ framework synthesis, we used the WHO-INTEGRATE framework as a starting point to develop the WHO-INTEGRATE COVID-19 framework version 1.0. WICID 1.0 is based on a content analysis of comprehensive strategy documents to guide policy makers in implementing new or decrease existing measures to protect against COVID-19 in Germany. WICID 1.0 was validated by coding the framework against an updated set of the key strategy documents, and key strategy documents addressing non-pharmacological measures in long-term care facilities. In total, 12 key strategy documents were analysed to develop WICID 1.0, and 18 + 23 documents were analyzed for its refinement towards WICID 2.0. The revised framework consists of 11 + 1 criteria and includes implications for the health of individuals and populations due to and beyond COVID-19, infringement on liberties and fundamental human rights, acceptability and equity considerations, societal, environmental and economic implications, as well as implementation, resource and feasibility considerations. Validation found high consistency with minor revisions between WICID 1.0 and 2.0. WICID can be a tool to support researchers, practitioners, and policy makers to systematically integrate evidence and ethics and to balance of health, societal and other considerations when reflecting on PH interventions targeting COVID-19. KEY MESSAGES: • Due to the rapidly developing pandemic, decision-making process often did not include the views of all affected stakeholders and did not adequately include all criteria and considerations of relevance. • The WICID Framework can serve as a tool to support decision-makers in accounting for relevant considerations and criteria, even when not all stakeholders could be included. Oxford University Press 2022-10-25 /pmc/articles/PMC9593559/ http://dx.doi.org/10.1093/eurpub/ckac129.543 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Arnold, L
Bimczok, S
Lehner, J
Stratil, J
WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title_full WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title_fullStr WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title_full_unstemmed WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title_short WICID 2.0: Integrating evidence and ethics in decisionmaking and guideline development on SARS-CoV-2: Jan Stratil
title_sort wicid 2.0: integrating evidence and ethics in decisionmaking and guideline development on sars-cov-2: jan stratil
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593559/
http://dx.doi.org/10.1093/eurpub/ckac129.543
work_keys_str_mv AT arnoldl wicid20integratingevidenceandethicsindecisionmakingandguidelinedevelopmentonsarscov2janstratil
AT bimczoks wicid20integratingevidenceandethicsindecisionmakingandguidelinedevelopmentonsarscov2janstratil
AT lehnerj wicid20integratingevidenceandethicsindecisionmakingandguidelinedevelopmentonsarscov2janstratil
AT stratilj wicid20integratingevidenceandethicsindecisionmakingandguidelinedevelopmentonsarscov2janstratil